Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$331K Buy
2,585
+99
+4% +$14K 0.01% 597
2026
Q2
$350K Buy
2,486
+1,496
+151% +$188K 0.01% 573
2026
Q1
$120K Sell
990
-772
-44% -$97.5K ﹤0.01% 822
2025
Q4
$240K Buy
1,762
+1,082
+159% +$160K 0.01% 647
2025
Q3
$108K Sell
680
-528
-44% -$89.7K ﹤0.01% 811
2025
Q2
$216K Buy
1,208
+298
+33% +$50.6K 0.01% 602
2025
Q1
$146K Buy
+910
New +$165K 0.01% 677
2023
Q4
– Sell
-13,157
Closed -$2.65M – 529
2023
Q3
$2.65M Buy
+13,157
New +$2.62M 0.15% 176
2022
Q3
– Sell
-288
Closed -$45K – 564
2022
Q2
$45K Buy
+288
New +$48.4K ﹤0.01% 693
2021
Q4
– Sell
-356
Closed -$65K – 418
2021
Q3
$65K Buy
356
+71
+25% +$13.4K 0.01% 532
2021
Q2
$50K Sell
285
-43
-13% -$7.41K ﹤0.01% 564
2021
Q1
$54K Buy
328
+167
+104% +$24.9K ﹤0.01% 474
2020
Q4
$21K Buy
161
+63
+64% +$8.25K ﹤0.01% 599
2020
Q3
$12K Buy
98
+86
+717% +$9.8K ﹤0.01% 638
2020
Q2
$1K Sell
12
-72
-86% -$7.8K ﹤0.01% 787
2020
Q1
$8K Buy
+84
New +$10.3K ﹤0.01% 475
2019
Q3
– Sell
-28
Closed -$3K – 812
2019
Q2
$3K Buy
+28
New +$2.94K ﹤0.01% 683

Other funds holding CDW

CX Institutional's CDW Position: Q3 2026 in Review

CX Institutional increased its CDW (CDW) stake by 4% in Q3 2026, buying an estimated $14K and bringing the position to 2,585 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #597.

CX Institutional first reported a position in CDW in Q2 2019 and has held it in 17 quarters since. The position peaked at $2.65M in Q3 2023. 162 funds tracked by Wall St. Rank hold CDW as of Q3 2026.

  • CX Institutional held 2,585 shares of CDW worth $331K as of Q3 2026.
  • CX Institutional bought 99 CDW shares in Q3 2026, an estimated $14K.
  • CDW made up 0.01% of CX Institutional's portfolio in Q3 2026, its #597 holding.
  • CX Institutional first reported a position in CDW in Q2 2019 and has held it in 17 quarters since.
  • CX Institutional's CDW position peaked at $2.65M in Q3 2023.
  • 162 funds tracked by Wall St. Rank held CDW as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.